Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Continueren van pimavanserine leidt tot minder terugval bij dementiegerelateerde psychose
aug 2021 | Dementie